Home/Filings/4/0001209191-19-041035
4//SEC Filing

Aldag Jorn 4

Accession 0001209191-19-041035

CIK 0001622229other

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 4:04 PM ET

Size

5.8 KB

Accession

0001209191-19-041035

Insider Transaction Report

Form 4
Period: 2019-07-01
Aldag Jorn
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-07-01$1.77/sh+7,608$13,5007,608 total
    Exercise: $2.41Exp: 2029-07-01Common Stock (7,608 underlying)
Footnotes (2)
  • [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.
  • [F2]This option is fully vested at time of grant.

Issuer

Unum Therapeutics Inc.

CIK 0001622229

Entity typeother

Related Parties

1
  • filerCIK 0001734412

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 4:04 PM ET
Size
5.8 KB